Updated ClosureFast™ radiofrequency ablation catheter receives U.S. FDA 510(k) clearance for treatment of chronic venous insufficiency

Join our community to access additional content!

CRT Community

$0.00

Register for Meetings

“In The News” & “Cardiovascular Marketplace” Content Access

Listen to Podcasts

Watch On-Demand Content

CardioTube Access

Access to Recorded Live Broadcasts from CRTvirtual Meetings, DMV, & Cath Conference

Access Recorded Interviews

Download PPT Slide Decks

Join Now!
Already have an account? Login Now

CRT Community Premium

~~$650.00 annually~~
$455.00 annually
Code: CRT30
Apply code at Checkout Offer Expires: May 31, 2025

Register for Meetings

“In The News” & “Cardiovascular Marketplace” Content Access

Listen to Podcasts

Watch On-Demand Content

CardioTube Access

Access to Recorded Live Broadcasts from CRTvirtual Meetings, DMV, & Cath Conference

Access Recorded Interviews

Download PPT Slide Decks

Complimentary subscription to electronic version of the CRM Journal

Access to CRT Meeting Registration Discounts

CRT Premium Content, including on-demand videos and presentation downloads

Join Now!
Already have an account? Login Now
News

Updated ClosureFast™ radiofrequency ablation catheter receives U.S. FDA 510(k) clearance for treatment of chronic venous insufficiency

Posted: 08/28/2023
2023 News News Articles

The ClosureFast™ catheter update brings new features including lower 6F profile and longer heating element for greater efficiency
1-3 of 4208 results
1 2 3 4 5 Next »

Calprotectin Plays Mechanistic Role in Development of ASCVD: Population-Based Study

May 07, 2025 by
Bailey G. Salimes, CRTonline.org

Calprotectin may be a biomarker for atherosclerotic cardiovascular disease (ASCVD), a new study shows.

DSE-Detected Ischemia Predicts PCI Efficacy: ORBITA-2 Data

May 07, 2025 by
Nathan Gray, CRTonline.org

The degree of ischemia detected on dobutamine stress echocardiography (DSE) strongly predicts the efficacy of percutaneous coronary intervention (PCI) in patients with stable coronary artery disease (CAD), according to a new analysis from the ORBITA-2 trial.

‘Modest’ Decline in Contrast During PCI, Focus on AKI Prevention

May 06, 2025 by
Nathan Gray, CRTonline.org

Contrast volume used during percutaneous coronary intervention (PCI) has shown a consistent but modest decline between 2018 and 2022, with less contrast used in patients at higher risk for acute kidney injury (AKI), according to a new analysis of national registry data.

1-3 of 4208 results
1 2 3 4 5 Next »

Most Viewed Pages

Catheter Ablation Significantly Reduces Functional MR and TR in AF with LVSD: 1-Year Multi-Study Analysis

Study Highlights Significant Benefit of Early Guideline-Directed Medical Therapy for HF

Novel Technique Employing Transcatheter Balloon-Expandable Valves in Pure Aortic Regurgitation: A Proof-of-Concept Study

SMART 2-Year Data Update & Panel Discussion

DMV (Apr 2025) Distal Left Main Bifurcation Stenting Case

Explore the Site

Stay Connected

CRT Group Foundation is a not for profit corporation dedicated to providing educational services in the field of cardiology through the website, CRTonline.org and the Cardiovascular Research Technologies (CRT) annual symposium. CRT focuses on the advances and changes in the field of cardiovascular medicine. CRT is designed to provide access to the world’s leading clinicians and the latest research in order to improve practice and treatment outcomes for a variety of health care professionals.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details

Join our community to access additional content!

CRT Community

CRT Community Premium

News

Updated ClosureFast™ radiofrequency ablation catheter receives U.S. FDA 510(k) clearance for treatment of chronic venous insufficiency

The ClosureFast™ catheter update brings new features including lower 6F profile and longer heating element for greater efficiency

Calprotectin Plays Mechanistic Role in Development of ASCVD: Population-Based Study

DSE-Detected Ischemia Predicts PCI Efficacy: ORBITA-2 Data

‘Modest’ Decline in Contrast During PCI, Focus on AKI Prevention

Most Viewed Pages

Explore the Site

Stay Connected